Isabelle Meyts obtained her medical degree at the Katholieke Universiteit Leuven, Belgium in 1999. In 2007 she obtained her license in Pediatrics. She obtained her PhD degree in 2007 with a work studying the role of Th subsets in allergic airway inflammation. At the University Hospitals Leuven, Belgium, she is responsible for the care for patients with primary immunodeficiency, hematopoietic stem cell transplantation included. Her efforts led to the recognition of the Department of Primary Immunodeficiencies as a Jeffrey Modell Foundation Diagnostics and Research Center in 2011. Her research mostly focused on the genetic and functional unraveling of primary immunodeficiency. Recent focus has been on DADA2, on the IFN-alpha pathway and on the PS-antibody response. In 2017 she was elected to become the next President of the European Society for Immunodeficiencies.